Inicio › Cáncer de estómago › Pensilvania

Ensayos clínicos de Cáncer de estómago en Pensilvania

30 estudios sobre Cáncer de estómago buscan participantes en Pensilvania.

Ciudades en Pensilvania

Texto oficial del estudio (inglés)

Distance-Based Exercise to Preserve Function and Prevent Disability

UPMC Hillman Cancer Center at Butler Health System, Butler
IRMC Cancer Center, Indiana
UPMC Hillman Cancer Center - New Castle, New Castle
y 2 más

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT07059884

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Christiana Care Health System-Concord Health Center, Chadds Ford
y 8 más

ReclutandoSe aceptan voluntarios sanos

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 oct 2026 · NCT07283939

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

Lehigh Valley Hospital-Cedar Crest, Allentown
Lehigh Valley Hospital - Muhlenberg, Bethlehem
Geisinger Medical Center, Danville
y 7 más

ReclutandoEstudio observacionalSe aceptan voluntarios sanos

Edades de 40 a 75 · Todos los sexos · Actualizado el 2 oct 2026 · NCT05334069

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Sidney Kimmell Cancer Center - Jefferson Health, Philadelphia

ReclutandoFase 1

Edades de 19 en adelante · Todos los sexos · Actualizado el 1 oct 2026 · NCT06586957

A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Nivolumab in Combination With Chemotherapy in Participants With Previously Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma (ROSETTA Gastric-204)

UPMC Hillman Cancer Center, Pittsburgh

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 30 sept 2026 · NCT07221149

Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer

Alliance Cancer Specialists, PC, Bensalem
Alliance Cancer Specialists, PC, Doylestown
Alliance Cancer Specialists, PC, Horsham
y 4 más

ReclutandoFase 2/3

Edades de 18 en adelante · Todos los sexos · Actualizado el 28 sept 2026 · NCT07392892

A Study of Novel Agents or Combinations as Perioperative Treatment in Participants With Locally Advanced Resectable Gastroesophageal Adenocarcinoma

Research Site, Pittsburgh

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 24 sept 2026 · NCT07069712

Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors

Allegheny Health Network, Pittsburgh

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT06128551

A Study of LY4257496 in Participants With Cancer (OMNIRAY)

University of Pittsburgh Medical Center, Pittsburgh

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07114601

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

University of Pennsylvania, Philadelphia
Fox Chase Cancer Center, Philadelphia

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 22 sept 2026 · NCT07213791

Prehabilitation in High-risk Oncologic Surgery

Fox Chase Cancer Center - Philadelphia, Philadelphia

Reclutando

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT07638410

Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients

Fox Chase Cancer Center, Philadelphia

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 sept 2026 · NCT05274048

Using 18F-FAPI PET to Detect Metastatic Disease in Patients That Have Gastric or Esophageal Cancer.

University of Pennsylvania, Perelman School of Medicine, Philadelphia

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 17 sept 2026 · NCT07217704

SKL35501 With SKL35502 Imaging in Adults With NTSR1 Positive Advanced Solid Tumors

UPMC Hillman Cancer Center, Pittsburgh

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 sept 2026 · NCT07812805

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

Research Site, Hershey
Research Site, Philadelphia
Research Site, Pittsburgh
y 3 más

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 9 sept 2026 · NCT07431281

A Clinical Study to Test if an Investigational Treatment Called BNT326 is Safe and Potentially Beneficial When Used Alone or in Combination With Other Investigational Treatments Such as BNT327, for People With Advanced Malignant Tumors

University of Pittsburgh Medical Center, Pittsburgh

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 2 sept 2026 · NCT07070232

A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors

Research Site, Pittsburgh

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 19 ago 2026 · NCT07115043

Study of TDXd, Chemotherapy, Pembrolizumab, and Trastuzumab in First-Line Metastatic HER2-Positive Gastric or Gastroesophageal Junction Cancer

Penn State University Milton S. Hershey Medical Center, Hershey

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 10 ago 2026 · NCT06731478

A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors

University of Pennsylvania, Philadelphia

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 jul 2026 · NCT03526835

A Study of CHS-114 (Tagmokitug) in Combination With Toripalimab and/or Other Treatments in Participants With Advanced Solid Tumors

University of Pittsburg Medical Center _UPMC Hillman Cancer Center, Pittsburgh

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 15 jul 2026 · NCT06657144

Lead-212 PSV359 Therapy for Patients With Solid Tumors

University of Pittsburgh Medical Center, Pittsburgh

ReclutandoFase 1/2

Edades de 18 a 90 · Todos los sexos · Actualizado el 6 jul 2026 · NCT06710756

A Study of PARG Inhibitor ETX-19477 in Patients With Advanced Solid Malignancies

Thomas Jefferson University, Sidney Kimmel Comprehensive Cancer Center, Philadelphia

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 mar 2026 · NCT06395519

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

UPMC Hillman Cancer Center, Pittsburgh
Guthrie Medical Group, PC and Robert Packer Hospital (Guthrie Cancer Center - Sayre), Sayre

ReclutandoFase 3

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 feb 2026 · NCT06532006

CTNNA1 Familial Expansion Study

Abramson Cancer Center of the University of Pennsylvania, Philadelphia

ReclutandoEstudio observacional

Edades de 18 en adelante · Todos los sexos · Actualizado el 5 feb 2026 · NCT05126290

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

University of Pennsylvania, Philadelphia

ReclutandoFase 1/2

Edades de 18 a 85 · Todos los sexos · Actualizado el 29 ene 2026 · NCT06055439

Cabozantinib Plus Durvalumab With or Without Tremelimumab in Patients With Gastroesophageal Cancer and Other Gastrointestinal Malignancies

UPMC Hillman Cancer Center, Pittsburgh

ReclutandoFase 1/2

Edades de 18 en adelante · Todos los sexos · Actualizado el 21 ene 2026 · NCT03539822

Adaptive Radiation for Abdominopelvic Metastases

Fox Chase Cancer Center, Philadelphia

ReclutandoFase 1

Edades de 18 en adelante · Todos los sexos · Actualizado el 29 oct 2025 · NCT05880667

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Massive Bio SYNERGY-AI site, Philadelphia

ReclutandoEstudio observacional

Todas las edades · Todos los sexos · Actualizado el 28 oct 2025 · NCT03452774

APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors

Penn State Milton S. Hershey Medical Center, Hershey

ReclutandoFase 2

Edades de 18 en adelante · Todos los sexos · Actualizado el 27 jun 2025 · NCT03175224

Intra-tumoral (IT) Injection of vvDD-hIL2-2-RG-1 for Metastatic Gastrointestinal and Peritoneal Tumors

AHN West Penn Hospital, Pittsburgh

ReclutandoFase 1

Edades de 18 a 69 · Todos los sexos · Actualizado el 3 jun 2025 · NCT07001592

De ClinicalTrials.gov, datos obtenidos el 5 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.